Thomas F. O’Brien
- Pulmonary and Respiratory Medicine
- Nephrology top 5%
- Molecular Biology
- Surgery
- Molecular Medicine top 5%
- Co-authors
- William H. HallCharles R. BaxterPaul E. TeschanRaymond U. OsarogiagbonAlbert H. CoonsJohn StellingRobert A. RamirezLaura E. Miller
- Topics
- Lung Cancer Diagnosis and Treatment (5 papers)Lung Cancer Treatments and Mutations (4 papers)Antibiotic Resistance in Bacteria (3 papers)
- Journals
- New England Journal of MedicineThe Journal of Experimental MedicineJournal of Clinical Oncology
- Partner nations
- United States
In The Last Decade
Thomas F. O’Brien
20 papers receiving 540 citations
Peers
Comparison fields: 5 of 82
- Pulmonary and Respiratory Medicine 180
- Nephrology 114
- Molecular Biology 91
- Surgery 89
- Molecular Medicine 76
Countries citing papers authored by Thomas F. O’Brien
This map shows the geographic impact of Thomas F. O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas F. O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas F. O’Brien more than expected).
Fields of papers citing papers by Thomas F. O’Brien
This network shows the impact of papers produced by Thomas F. O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas F. O’Brien. The network helps show where Thomas F. O’Brien may publish in the future.
Co-authorship network of co-authors of Thomas F. O’Brien
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas F. O’Brien. A scholar is included among the top collaborators of Thomas F. O’Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas F. O’Brien. Thomas F. O’Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 24 | |
| 3 | 78 | |
| 4 | 40 | |
| 5 | 8 | |
| 6 | 0 | |
| 7 | 11 | |
| 8 | 9 | |
| 9 | 90 | |
| 10 | Infection control surveillance in a rehabilitation hospital. | 1 |
| 11 | 5 | |
| 12 | 62 | |
| 13 | 5 | |
| 14 | 12 | |
| 15 | Holy Cross football team hepatitis outbreak. | 7 |
| 16 | 1 | |
| 17 | 12 | |
| 18 | 38 | |
| 19 | 142 | |
| 20 | 3 |
About Thomas F. O’Brien
Thomas F. O’Brien is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Otorhinolaryngology, having authored 22 papers that have together received 610 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Nephrology (114 citations), Molecular Medicine (76 citations) and Applied Microbiology and Biotechnology (27 citations). Thomas F. O’Brien has collaborated with scholars based in United States. Frequent co-authors include William H. Hall, Charles R. Baxter, Paul E. Teschan, Raymond U. Osarogiagbon, Albert H. Coons, John Stelling, Robert A. Ramirez, Laura E. Miller, Xinhua Yu and Dennis A. Steindler. Their work appears in journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.